BioLife Solutions Acquires Stirling Ultracold
March 22, 2021
BioLife Solutions, Inc. agreed to acquire Global Cooling, Inc., operating as Stirling Ultracold, in an all-stock merger in which BioLife will issue 6,646,870 shares to acquire 100% of Stirling. The deal (expected to close in early Q2 2021) expands BioLife's cold-chain and ULT freezer product portfolio, adds Stirling’s ~150 employees and IP, and is expected to be accretive on an adjusted net income per share basis in 2022 and beyond.
- Buyers
- BioLife Solutions, Inc.
- Targets
- Global Cooling, Inc. (operating as Stirling Ultracold)
- Sellers
- Stirling shareholders
- Industry
- Manufacturing
- Location
- Ohio, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Repligen Acquires BioLife Solutions for $1.5 Billion
July 23, 2026
Healthcare Services
Repligen has entered into a definitive agreement to acquire BioLife Solutions in a cash-and-stock transaction with an enterprise value of approximately $1.5 billion. The deal is expected to close in the fourth quarter of 2026, subject to BioLife shareholder approval and regulatory clearances.
-
Vertiv Acquires Strategic Thermal Labs LLC
April 27, 2026
IT Services
Vertiv announced it has acquired Strategic Thermal Labs LLC (STL), a specialist in advanced liquid-cooling technologies. The acquisition strengthens Vertiv’s thermal-chain strategy—especially engineering capability around cold-plate design, server-side liquid cooling, and high-density thermal validation for AI and high-performance computing workloads.
-
Ecolab Acquires CoolIT Systems for $4.75 Billion
March 27, 2026
IT Services
Ecolab agreed to acquire Calgary-based liquid cooling technology provider CoolIT Systems for about US$4.75 billion in cash. The deal expands Ecolab’s Global High-Tech growth engine and strengthens its Cooling-as-a-Service offering for AI data centers by combining CoolIT’s direct-to-chip liquid cooling with Ecolab’s water, chemistry, and digital services expertise.
-
BioLife Solutions Acquires PanTHERA CryoSolutions
April 10, 2025
Biotechnology
BioLife Solutions acquired the remaining 90% of PanTHERA CryoSolutions for $9.3 million in cash plus 241,355 shares of BioLife common stock, with up to an additional $7.2 million of stock payable upon achievement of milestones. The acquisition adds PanTHERA's proprietary Ice Recrystallization Inhibitor (IRI) technology and scientific talent to BioLife's biopreservation consumables portfolio, accelerating product capability development for the cell and gene therapy market.
-
Standex Acquires Custom Biogenic Systems from BioLife Solutions
November 14, 2024
Manufacturing
Standex International has acquired Custom Biogenic Systems (CBS), a Michigan-based maker of cryogenic and controlled-rate freezers, from BioLife Solutions for approximately $6.1–$6.2 million in cash. The business will be reported in Standex's Scientific segment and is expected to be accretive in year one, expanding Standex's scientific refrigeration capabilities and North American manufacturing footprint.
-
Milton Street Capital Forms IC Biomedical by Acquiring Worthington Life Sciences Business and International Cryogenics
November 2, 2020
Medical Devices
Milton Street Capital, a Houston-based private equity firm, acquired the Life Sciences business of Worthington Industries (Theodore, AL) and International Cryogenics, Inc. (Indianapolis, IN) and combined them to form IC Biomedical. The new company will be led by Steve Shaw (CEO) and Jim Hoppel (CFO) and will focus on manufacturing cryogenic storage freezers, dewars and shippers for biomedical, pharmaceutical and research markets.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.